Here are the S-3 shelf registrations from Enveric Biosciences, Inc. (ENVB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow ENVB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENVB filings page.
Enveric Biosciences, Inc. is registering the offer and resale of up to 6,822,225 shares of its common stock.
The registration covers resale by selling stockholders of (i) 98,000 shares issued in a private placement, (ii) 2,124,223 shares issuable upon exercise of pre-funded warrants, (iii) 2,222,223 shares issuable upon exercise of Series I Warrants, (iv) 2,222,223 shares issuable upon exercise of Series J Warrants, and (v) 155,556 shares issuable upon exercise of placement agent warrants. The company will receive no proceeds from resales; the selling holders may sell from time to time at prevailing market or negotiated prices. The registration relates to resale rights granted in connection with a Private Placement and includes customary beneficial ownership limits of 4.99% and 9.99% on warrant exercise; sales are subject to the plan of distribution described in the prospectus.